Your browser doesn't support javascript.
Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Liu, Yi-Chun Carol; Munoz, Flor M; Izurieta, Hector S; Tamborska, Arina A; Solomon, Tom; Law, Barbara J; Chhabra, Nipun.
  • Liu YC; Department of Surgery, Division of Pediatric Otolaryngology, Baylor College of Medicine, and Texas Children's Hospital, Houston, TX, USA. Electronic address: Yi-Chun.Liu@bcm.edu.
  • Munoz FM; Department of Pediatrics, Division of Infectious Diseases, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Izurieta HS; Office of Vaccine Research and Review (OVRR), CBER, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Tamborska AA; National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Merseyside, United Kingdom; Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, Uni
  • Solomon T; National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Merseyside, United Kingdom.
  • Law BJ; Brighton Collaboration, Decatur, GA, USA.
  • Chhabra N; Department of Otolaryngology, Case Western Reserve University, Cleveland, OH, USA; VA Northeast Ohio Healthcare System, Cleveland, OH, USA; University Hospitals Ear, Nose & Throat Institute, Cleveland, OH, USA.
Vaccine ; 41(11): 1902-1910, 2023 03 10.
Article in English | MEDLINE | ID: covidwho-2232642
ABSTRACT
This is a Brighton Collaboration case definition of anosmia to be used in the evaluation of adverse events following immunization, and for epidemiologic studies for the assessment of background incidence or hypothesis testing. The case definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of SARS-CoV-2 vaccines. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by two expert reviewers prior to submission.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study Topics: Vaccines Limits: Humans Language: English Journal: Vaccine Year: 2023 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study Topics: Vaccines Limits: Humans Language: English Journal: Vaccine Year: 2023 Document Type: Article